Why the study?
Does raoulic acid inhibit human rhinovirus replication in vitro?
Does raoulic acid inhibit human rhinovirus replication in vitro?
Raoulic acid demonstrates broad-spectrum in vitro antiviral activity against multiple human rhinovirus serotypes.
Answers are grounded in this paper and cite their sources.
Raoulic acid may merit preclinical development for HRV; leaves open translation to in vivo or clinical efficacy.
Human rhinoviruses (HRVs), members of the Picornaviridae family, are composed of over 100 different virus serotypes. Until now there is no recorded clinically effective antiviral chemotherapeutic agent for treatment of diseases caused by HRVs. Our previous study of raoulic acid tested against serotype human rhinoviruses showed anti-HRV2 (species A) and -3 (species B) activities. In this study, raoulic acid was found to possess broad-spectrum antiviral activity against six HRVs with a 50% inhibition concentration of less than 9.5 microg/mL through inhibition of the cellular absorption of the HRV particles. Furthermore, the effect of raoulic acid on resistance of HRV5 exhibited to pleconaril was more pronounced than the effect on HRV1b, -6, -14, -15, and -40. However, ribavirin did possess weak antiviral activity against HRVs. Collectively, the results demonstrate that raoulic acid is a novel therapeutic candidate for two different groups of human rhinovirus.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: